Back to Search
Start Over
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
The Spiegelmer NOX-A12, a novel CXCL12 inhibitor, interferes with chronic lymphocytic leukemia cell motility and causes chemosensitization
- Source :
- Blood. 123:1032-1039
- Publication Year :
- 2014
- Publisher :
- American Society of Hematology, 2014.
-
Abstract
- The CXC chemokine ligand (CXCL12, or stromal cell-derived factor-1 as previously known) plays a critical role for homing and retention of chronic lymphocytic leukemia (CLL) cells in tissues such as the bone marrow (BM). In tissues, stromal cells constitutively secrete and present CXCL12 via cell-surface-bound glycosaminoglycans (GAGs), thereby attracting CLL cells and protecting them from cytotoxic drugs, a mechanism that may account for residual disease after conventional CLL therapy. NOX-A12, an RNA oligonucleotide in L-configuration (Spiegelmer) that binds and neutralizes CXCL12, was developed for interference with CXCL12 in the tumor microenvironment and for cell mobilization. Here, we examined effects of NOX-A12 on CLL cell migration and drug sensitivity. We found that NOX-A12 effectively inhibited CXCL12-induced chemotaxis of CLL cells. In contrast, NOX-A12 increased CLL migration underneath a confluent layer of BM stromal cells (BMSCs) due to interference with the CXCL12 gradient established by BMSCs. In particular, NOX-A12 competes with GAGs such as heparin for CXCL12 binding, leading to the release of CXCL12 from stromal cell-surface-bound GAGs, and thereby to neutralization of the chemokine. Furthermore, NOX-A12 sensitizes CLL cells toward bendamustine and fludarabine in BMSC cocultures. These data demonstrate that NOX-A12 effectively interferes with CLL cell migration and BMSC-mediated drug resistance, and establishes a rationale for clinical development of NOX-A12 in combination with conventional agents in CLL.
- Subjects :
- Chemokine
Stromal cell
Chronic lymphocytic leukemia
Immunology
Cell
Drug Evaluation, Preclinical
Antineoplastic Agents
Biochemistry
Jurkat Cells
Transcellular Cell Migration
Cell Movement
hemic and lymphatic diseases
medicine
Humans
Cytotoxic T cell
Lymphocytes
Cells, Cultured
Tumor microenvironment
biology
Drug Synergism
Mesenchymal Stem Cells
Cell migration
Cell Biology
Hematology
Aptamers, Nucleotide
medicine.disease
Leukemia, Lymphocytic, Chronic, B-Cell
Chemokine CXCL12
Recombinant Proteins
biological factors
medicine.anatomical_structure
Drug Resistance, Neoplasm
biology.protein
Cancer research
Bone marrow
Subjects
Details
- ISSN :
- 15280020 and 00064971
- Volume :
- 123
- Database :
- OpenAIRE
- Journal :
- Blood
- Accession number :
- edsair.doi.dedup.....4935b6ec56f180b2bf829b1cb4274ab3
- Full Text :
- https://doi.org/10.1182/blood-2013-03-493924